Synthetic Biology & Health
Overview
The seminal achievements of constructing the first synthetic bacterial cell and first minimal cell are key to understanding fundamentals of biology. This work is also expanding the ability to produce various kinds of biologically-based products including new types of medicine and renewable fuels. As the team progresses on their science goals, they are equally focused on the societal implications of this work. Synthetic genomics holds great promise for the future, and our team is at the forefront of discoveries and important public dialogue.
First Self-Replicating Synthetic Bacterial Cell
First Minimal Synthetic Bacterial Cell
Projects
Designer Phage
Synthetic Engineering of Bacteriophage for Treatment of Wound InfectionsViral Synthetic Genomics to Engineer Large dsDNA Viruses
Rapid engineering of large dsDNA viruses using synthetic genomics assembly tools.
Assembly of HSV-1
Use of cutting-edge synthetic genomics technology to revolutionize the study of herpesvirus biology.
A Synthetic Human Cytomegalovirus Vaccine Platform
Generation of an HCMV low passage clinical isolate using synthetic genomics.
Team
News
Tae Seok Moon, Ph.D. and Nan Zhu, Ph.D. join J. Craig Venter Institute faculty
JCVI continues to actively recruit faculty to expand core research areas, including human health and synthetic biology
Scientists develop method to efficiently construct single-copy human artificial chromosomes (HACs)
This new tool will allow scientists to work in mammalian systems in ways only previously available in bacteria and yeast
HACs have wide potential research applications to synthetic biologists and may eventually aid in delivering DNA in clinical applications
12th Build-a-Cell Workshop hosted at J. Craig Venter Institute in La Jolla
The workshop will take place March 29, 2024 with registration closing March 19
J. Craig Venter Institute contracted by the Centers for Disease Control and Prevention to rapidly construct synthetic influenza genes
Genes will be used to help develop seasonal and pandemic vaccines, improving response time and vaccine efficacy
BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic
Collaboration seeks to develop an oncolytic virus that incorporates a novel, precision-targeted approach to improve safety and efficacy
Synthetic genomics advances and promise
Advances in DNA synthesis will enable extraordinary new opportunities in medicine, industry, agriculture, and research
Hamilton O. Smith, M.D., Synthetic Biology Pioneer and Nobel Laureate, to Step Down from Daily Duties at J. Craig Venter Institute
Dr. Smith will maintain advisory role as professor emeritus
After saving countless lives, Nobel laureate Hamilton Smith retires as his own health falters
He has been a fixture in San Diego science for decades
Synthetic Cell-Powered Lotion to Manage Type 1 Diabetes
2019 Summer Internship Program
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage
No More Needles! Using Microbiome and Synthetic Biology Advances to Better Treat Type 1 Diabetes
JCVI Team Awarded Two Grants Under the National Science Foundation’s “Understanding the Rules of Life” Initiative, Building on 20 Years of JCVI Research
NSF announces new awards for Understanding the Rules of Life
New projects address genetic, environmental causality in biological systems and processes